$ELMD
Electromed, Inc. Stock $elmd

$elmd Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000089710123000477 Filed on November 07, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$13.69M	$12.32M
YoY Change	16.71%	15.63%
Cost Of Revenue	$3.144M	$2.826M
YoY Change	3.18%	21.44%
Gross Profit	$10.55M	$9.498M
YoY Change	21.46%	14.01%
Gross Profit Margin	77.03%	77.07%
Selling, General & Admin	$8.175M	$9.150M
YoY Change	12.7%	14.53%
% of Gross Profit	77.52%	96.34%
Research & Development	$107.0K	$206.0K
YoY Change	-30.52%	-30.87%
% of Gross Profit	1.01%	2.17%
Depreciation & Amortization	$209.0K	$202.0K
YoY Change	26.67%	50.75%
% of Gross Profit	1.98%	2.13%
Operating Expenses	$8.282M	$9.356M
YoY Change	11.8%	12.9%
Operating Profit	$2.263M	$142.0K
YoY Change	77.63%	222.73%
Interest Expense	$96.00K	$77.00K
YoY Change	1271.43%	1825.0%
% of Operating Profit	4.24%	54.23%
Other Income/Expense, Net
YoY Change
Pretax Income	$2.359M	$219.0K
YoY Change	84.15%	356.25%
Income Tax	$685.0K	$64.00K
% Of Pretax Income	29.04%	29.22%
Net Earnings	$1.674M	$155.0K
YoY Change	71.34%	91.36%
Net Earnings / Revenue	12.23%	1.26%
Basic Earnings Per Share	$0.20	$0.02
Diluted Earnings Per Share	$0.19	$0.02
COMMON SHARES
Basic Shares Outstanding	8.582M shares	8.555M shares
Diluted Shares Outstanding	8.800M shares	8.783M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.43M	$7.024M
YoY Change	51.02%	17.11%
Cash & Equivalents	$10.43M	$7.024M
Short-Term Investments
Other Short-Term Assets	$509.0K	$692.0K
YoY Change	-70.41%	-65.66%
Inventory	$4.760M	$4.480M
Prepaid Expenses
Receivables	$22.99M	$23.46M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$39.27M	$36.20M
YoY Change	14.93%	8.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.377M	$5.534M
YoY Change	6.73%	18.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$125.0K	$143.0K
YoY Change	56.25%	43.0%
Total Long-Term Assets	$7.699M	$7.871M
YoY Change	6.49%	13.84%
TOTAL ASSETS
Total Short-Term Assets	$39.27M	$36.20M
Total Long-Term Assets	$7.699M	$7.871M
Total Assets	$46.96M	$44.07M
YoY Change	13.46%	9.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.041M	$1.057M
YoY Change	32.61%	-16.44%
Accrued Expenses	$3.796M	$3.185M
YoY Change	0.98%	-4.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.573M	$5.776M
YoY Change	9.35%	-2.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$49.00K	$68.00K
YoY Change	48.48%	83.78%
Total Long-Term Liabilities	$49.00K	$68.00K
YoY Change	48.48%	83.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.573M	$5.776M
Total Long-Term Liabilities	$49.00K	$68.00K
Total Liabilities	$6.622M	$5.844M
YoY Change	9.56%	-2.44%
SHAREHOLDERS EQUITY
Retained Earnings	$20.62M	$18.95M
YoY Change	23.6%	20.57%
Common Stock	$86.00K	$86.00K
YoY Change	1.18%	1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$40.34M	$38.22M
YoY Change
Total Liabilities & Shareholders Equity	$46.96M	$44.07M
YoY Change	13.46%	9.8%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$1.674M	$155.0K
YoY Change	71.34%	91.36%
Depreciation, Depletion And Amortization	$209.0K	$202.0K
YoY Change	26.67%	50.75%
Cash From Operating Activities	$3.471M	-$244.0K
YoY Change	154.47%	-85.6%
INVESTING ACTIVITIES
Capital Expenditures	$87.00K	$109.0K
YoY Change	-81.13%	-54.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$87.00K	-$133.0K
YoY Change	-81.13%	-48.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	26.00K	$29.00K
YoY Change	225.0%	-114.15%
NET CHANGE
Cash From Operating Activities	3.471M	-$244.0K
Cash From Investing Activities	-87.00K	-$133.0K
Cash From Financing Activities	26.00K	$29.00K
Net Change In Cash	3.410M	-$348.0K
YoY Change	274.31%	-83.85%
FREE CASH FLOW
Cash From Operating Activities	$3.471M	-$244.0K
Capital Expenditures	$87.00K	$109.0K
Free Cash Flow	$3.384M	-$353.0K
YoY Change	274.75%	-81.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001488917
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions		usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q3	elmd	Intangible Asset Acquisitions In Accounts Payable IntangibleAssetAcquisitionsInAccountsPayable		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	487000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	487000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-33000	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y2M30D
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	001-34839
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	Electromed, Inc.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1732920
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Sixth Avenue NW
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	New Prague
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	56071
CY2023Q3	dei	City Area Code CityAreaCode	952
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	758-9299
CY2023Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023Q3	dei	Trading Symbol TradingSymbol	ELMD
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8581677	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7024000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7372000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23455000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24130000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	544000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	487000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4480000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	4221000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	692000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1577000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	36195000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	37787000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5534000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5672000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	613000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	605000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	143000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	161000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1581000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1581000	usd
CY2023Q3	us-gaap	Assets Assets	44066000	usd
CY2023Q2	us-gaap	Assets Assets	45806000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1057000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1372000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1844000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3018000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	110000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	336000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1424000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1378000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1341000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1949000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5776000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8053000	usd
CY2023Q3	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	68000	usd
CY2023Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	86000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5844000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	8139000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8579050	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8579050	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8555238	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8555238	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	86000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	86000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19188000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18788000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18948000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18793000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38222000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	37667000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44066000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45806000	usd
CY2023Q3	us-gaap	Revenues Revenues	12324000	usd
CY2022Q3	us-gaap	Revenues Revenues	10658000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2826000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	2327000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	9498000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	8331000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9150000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7989000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	206000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	298000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	9356000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	8287000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	142000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	44000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	77000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	219000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	48000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-33000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	155000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	81000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8537388	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8445893	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8782824	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8689377	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	155000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	81000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	202000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	134000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	371000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	95000	usd
CY2022Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-675000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-95000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	57000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	167000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	240000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	500000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-901000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	125000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-226000	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-175000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-863000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-26000	usd
CY2023Q3	elmd	Accrued Compensation AccruedCompensation	1174000	usd
CY2022Q3	elmd	Accrued Compensation AccruedCompensation	1132000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-244000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1694000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	109000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	241000	usd
CY2023Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	24000	usd
CY2022Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	15000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-256000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	29000	usd
CY2022Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	60000	usd
CY2022Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	145000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-205000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-348000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2155000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7372000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8153000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7024000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5998000	usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	251000	usd
CY2022Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	135000	usd
CY2023Q3	elmd	Property And Equipment Acquisitions In Accounts Payable PropertyAndEquipmentAcquisitionsInAccountsPayable	34000	usd
CY2022Q3	elmd	Property And Equipment Acquisitions In Accounts Payable PropertyAndEquipmentAcquisitionsInAccountsPayable	46000	usd
CY2022Q3	elmd	Intangible Asset Acquisitions In Accounts Payable IntangibleAssetAcquisitionsInAccountsPayable	9000	usd
CY2023Q3	elmd	Demonstration Equipment Returned To Inventory DemonstrationEquipmentReturnedToInventory	19000	usd
CY2022Q3	elmd	Demonstration Equipment Returned To Inventory DemonstrationEquipmentReturnedToInventory	5000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	34173000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	81000	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-60000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	95000	usd
CY2022Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	145000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	34144000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	37667000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	155000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	29000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	371000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38222000	usd
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zIxkm17hYrO6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_86B_z9CF365vgdud">Use of estimates.</span> </b>Management uses estimates and assumptions in preparing the unaudited Condensed Financial Statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used. The Company believes the critical accounting policies that require the most significant assumptions and judgments in the preparation of its unaudited Condensed Financial Statements include revenue recognition and the related estimation of variable consideration, inventory valuation, share-based compensation and warranty reserve.</p>
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	403944	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	212023	shares
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12324000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10658000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	286000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-447000	usd
CY2023	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-1220000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	761000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1351000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	-258000	usd
CY2023	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	71000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	544000	usd
CY2023Q3	us-gaap	Other Inventory Supplies OtherInventorySupplies	3559000	usd
CY2023Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	3420000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	500000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	470000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	518000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	323000	usd
CY2023Q3	us-gaap	Other Inventory In Transit OtherInventoryInTransit	263000	usd
CY2023Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	265000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	360000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	257000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4480000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	4221000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1378000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1256000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	153000	usd
CY2023	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	416000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	107000	usd
CY2023	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	294000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1424000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1378000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.293	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.688	pure
CY2022Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	44000	usd
CY2023Q3	elmd	Debt Instrument Covenant Compliance Amount DebtInstrumentCovenantComplianceAmount	10125000	usd
CY2023Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	239995	shares
CY2023Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2725000	usd
CY2023Q3	us-gaap	Share Price SharePrice	11.36
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	371000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	95000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0407	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0443	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0288	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0423	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.53	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.53	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.54	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1740000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	697552	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	375673	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1717000	usd
CY2023Q3	elmd	Unrecognized Compensation Expense UnrecognizedCompensationExpense	1444000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.72
CY2023Q3	us-gaap	Loss Contingency Settlement Agreement Date LossContingencySettlementAgreementDate	July 10, 2023
CY2023Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	825000	usd

Files In Submission

Name	View Source	Status
0000897101-23-000477-index-headers.html	Edgar Link	pending
0000897101-23-000477-index.html	Edgar Link	pending
0000897101-23-000477.txt	Edgar Link	pending
0000897101-23-000477-xbrl.zip	Edgar Link	pending
elmd-20230930.xsd	Edgar Link	pending
elmd231140_10q.htm	Edgar Link	pending
elmd231140_ex31-1.htm	Edgar Link	pending
elmd231140_ex31-2.htm	Edgar Link	pending
elmd231140_ex32-1.htm	Edgar Link	pending
elmd231140_ex32-2.htm	Edgar Link	pending
elmd-20230930_cal.xml	Edgar Link	unprocessable
elmd-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
elmd-20230930_lab.xml	Edgar Link	unprocessable
elmd-20230930_pre.xml	Edgar Link	unprocessable
elmd231140_10q_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELMD
Electromed, Inc. Stock $elmd

2023 Q4 Form 10-Q Financial Statement

#000089710123000477 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELMD Electromed, Inc. Stock $elmd

2023 Q4 Form 10-Q Financial Statement

#000089710123000477 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELMD
Electromed, Inc. Stock $elmd